Evidence map›Paper›PMID 41893343›Full record

ArticleMetabolites2026

Glycated High-Density Lipoproteins Reduce Endothelial Phenotypic Expression of Monocyte-Derived Multipotential Cells in Early Type 2 Diabetes.

Felipe Massó-Rojas, Luis Felipe Montaño-Estrada, Araceli Páez-Arenas, Juan Gabriel Juárez-Rojas, Aida Medina-Urrutia, Rafael Nambo-Venegas, Emma Rodríguez-Maldonado, Esteban Jorge-Galarza

Abstract read
In one paragraph

Article in Metabolites, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Felipe Massó-RojasLaboratory of Translational Medicine, UNAM-INC Research Unit, National Institute of Cardiology Ignacio Chávez, Mexico City 14080, Mexico.
Luis Felipe Montaño-EstradaInmunobiology Laboratory, Department of Cellular and Tissue Biology, Faculty of Medicine, Universidad Nacional Autónoma de Mexico (UNAM), Mexico City 04510, Mexico.ORCID 0000-0002-2019-3140
Araceli Páez-ArenasLaboratory of Translational Medicine, UNAM-INC Research Unit, National Institute of Cardiology Ignacio Chávez, Mexico City 14080, Mexico.ORCID 0000-0003-4688-8271
Juan Gabriel Juárez-RojasPharmacology Department, National Institute of Cardiology Ignacio Chávez, Mexico City 14080, Mexico.ORCID 0000-0001-8864-2304
Aida Medina-UrrutiaPharmacology Department, National Institute of Cardiology Ignacio Chávez, Mexico City 14080, Mexico.
Rafael Nambo-VenegasLaboratory of Chronic Diseases Biochemistry, National Genomics Medicine Institute (INMEGEN), Mexico City 14080, Mexico.
Emma Rodríguez-MaldonadoLaboratory of Translational Medicine, UNAM-INC Research Unit, National Institute of Cardiology Ignacio Chávez, Mexico City 14080, Mexico.
Esteban Jorge-GalarzaInmunobiology Laboratory, Department of Cellular and Tissue Biology, Faculty of Medicine, Universidad Nacional Autónoma de Mexico (UNAM), Mexico City 04510, Mexico.ORCID 0000-0002-7748-4678

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

advanced glycation productsendothelial progenitor cellshigh-density lipoproteinshigh-density lipoprotein sizenewly diagnosed type 2 diabetes

Identifiers

PMID41893343
PMCPMC13027787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.